date,title,source
Oct-18-18,"Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-24-18,"Jaguar Health, Inc. to Host Investor Meetings at Dawson James Small Cap Growth Conference Tuesday, October 30, 2018 in Jupiter, Florida",ACCESSWIRE
Oct-29-18,The Brilliance Behind a Global Operator of Crypto Exchanges BitMax: Understanding the Trans-Fee Mining Model,ACCESSWIRE
Oct-29-18,"Jaguar Health, Inc. Expects to File Third-Quarter 2018 Financial Results November 14th",ACCESSWIRE
Nov-13-18,"Reminder: Jaguar Health, Inc. Will Release 3Q'18 Financial Results After Market on November 14th",ACCESSWIRE
Nov-14-18,"Jaguar Health, Inc. Reports Third-Quarter 2018 Results",ACCESSWIRE
Dec-06-18,"Jaguar Health, Inc. Engages T.R. Winston & Company to Advise on Collaboration, Licensing and Development Activities Related to Mytesi and Crofelemer",ACCESSWIRE
Jan-02-19,Jaguar Health to Host Investor Call January 7th at 8 a.m. Eastern to Review 4Q'18 Performance,ACCESSWIRE
Jan-03-19,Jaguar Health to Present at Biotech Showcase 2019 in San Francisco,ACCESSWIRE
Jan-07-19,Jaguar Health Provides Fourth Quarter 2018 Commercial Sales Updates,ACCESSWIRE
Jan-09-19,"Jaguar Health Receives First Order for First-Generation of Equilevia, the Company's Non-Prescription, Personalized, Premium Product for Total Gut Health in High-Performance Equine Athletes",ACCESSWIRE
Jan-22-19,Jaguar Health to Present at Noble Capital Markets Annual Investor Conference January 28 in Fort Lauderdale,ACCESSWIRE
Jan-24-19,"With the Addition of Mytesi to the Formulary for Florida's AIDS Drug Assistance Program (ADAP), Approximately 86% of ADAP-Eligible US Lives Now Have Access to Jaguar Health's FDA-Approved Drug Product",ACCESSWIRE
Feb-21-19,"What Kind Of Shareholders Own Jaguar Health, Inc. (NASDAQ:JAGX)?",Simply Wall St.
Feb-25-19,"Jaguar Health Announces Adjournment of Special Meeting of Stockholders Until Thursday, February 28, 2019",ACCESSWIRE
Mar-05-19,"Jaguar Health, Inc. Reports Voting Results from February 28, 2019 Special Meeting of Stockholders",ACCESSWIRE
Mar-18-19,Four Healthcare Stocks Heating Up On Monday,ACCESSWIRE
Mar-20-19,Jaguar Completes Filing of CMC Technical Section with FDA for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs,ACCESSWIRE
Mar-27-19,Four Biotech Stocks Setting The Standard On Wednesday,ACCESSWIRE
Mar-28-19,Jaguar Health Issues Regulatory Update Regarding Potential Follow-on Indication for Mytesi,ACCESSWIRE
Apr-01-19,"Jaguar Health, Pipeline Review and Progress",ACCESSWIRE
Apr-02-19,Jaguar Health Subsidiary Napo Pharmaceuticals Issues Further Regulatory Update Regarding Potential Follow-on Indication for Mytesi,ACCESSWIRE
Apr-10-19,"Jaguar Health, Inc. Reports 2018 Fourth Quarter and Year End Financial Results",ACCESSWIRE
Apr-25-19,Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief,ACCESSWIRE
May-24-19,"Jaguar Health, Inc. Reports Voting Results from May 24, 2019 Annual Meeting of Stockholders",ACCESSWIRE
May-24-19,"Jaguar Health, Inc. Reports 2019 First Quarter Financial Results",ACCESSWIRE
